Alternatively spliced isoforms of FE65 serve as neuron-specific and non- neuronal markers

Journal of Neuroscience Research

Volumn 58, Issue 5, 1999, Pages 632-640

  Hu, Qub ai ^a   Hearn, Mark G ^a   Jin, Lee Way ^a   Bressler, Steven L ^a   Martin, George M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Alternative splicing; Alzheimer's disease; Neuronal marker; Quantitative RT PCR; RE65

Indexed keywords

BIOLOGICAL MARKER; BRAIN PROTEIN; ISOPROTEIN;

AGED; ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CASE REPORT; EXON; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NERVE CELL; NERVE CELL DIFFERENTIATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SPECIFICITY;

AGED; AGED, 80 AND OVER; ALTERNATIVE SPLICING; ANIMALS; BIOLOGICAL MARKERS; BRAIN CHEMISTRY; EXONS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MICE; NERVE TISSUE PROTEINS; NEURONS; NUCLEAR PROTEINS; PROTEIN ISOFORMS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0033485891     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19991201)58:5<632::AID-JNR4>3.0.CO;2-P     Document Type: Article

References (28)

1. Bain G, Ray WJ, Yao M, Gottlieb DI. 1994. From embryonal carcinoma cells to neurons: the P19 pathway. Bioessays 16:343-348.
2. Borg JP, Ooi J, Levy E, Margolis B. 1996. The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol Cell Biol 16:6229-6241.
3. Braak H, Braak E. 1997. Frequency of stages of Alzheimer-related lesions in different age categories. Neuronbiol Aging 18:351-357.
4. Bressler SL, Gray MD, Sopher BL, Hu Q, Hearn MG, Pham DG, Dinulos MB, Fukuchi K, Sisodia SS, Miller MA, Disteche CM, Martin GM. 1996. cDNA cloning and chromosome mapping of the human Fe65 gene: interaction of the conserved cytoplasmic domains of the human beta-amyloid precursor protein and its homologues with the mouse Fe65 protein. Hum Mol Genet 5:1589-1598.
5. Ciccarone V, Spengler BA, Meyers MB, Biedler JL, Ross RA. 1989. Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res 49:219-225.
6. De Strooper B, Umans L, van Leuven F, Van Den Berghe H. 1993. Study of the synthesis and secretion of normal and artificial mutants of murine amyloid precursor protein (APP): cleavage of APP occurs in a late compartment of the default secretion pathway. J Cell Biol 121:295-304.
7. Duilio A, Zambrano N, Mogavero AR, Ammendola R, Cimino F, Russo T. 1991. A rat brain mRNA encoding a transcriptional activator homologous to the DNA binding domain of retroviral integrases. Nucleic Acids Res 19:5269-5274.
8. Ermekova KS, Zambrano N, Linn H, Minopoli G, Gertler F, Russo T, Sudol M. 1997. The WW domain of neural protein FE65 interacts with proline-rich motifs in Mena, the mammalian homolog of Drosophila Enabled. J Biol Chem 272:32869-32877.
9. Fiore F, Zambrano N, Minopoli G, Donini V, Duilio A, Russo T. 1995. The regions of the Fe65 protein homologous to the phosphotyrosine interaction/phosphotyrosine binding domain of She bind the intracellular domain of the Alzheimer's amyloid precursor protein. J Biol Chem 270:30853-30856.
10. Freshney RI. 1994. Culture of animal cells. New York: Wiley-Liss. 337 p.
11. Fukuchi K, Deeb SS, Kamino K, Ogburn CE, Snow AD, Sekiguchi RT, Wight TN, Piussan H, Martin GM. 1992. Increased expression of β-amyloid protein precursor and microtubule-associated protein Τ during the differentiation of murine embryonal carcinoma cells. J Neurochem 58:1863-1873.
12. Hanada M, Krajewski S, Tanaka S, Cazals-Hatem D, Spengler BA, Ross RA, Biedler JL, Reed JC. 1993. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells. Cancer Res 53:4978-4986.
13. Hu Q, Kukull WA, Bressler SL, Gray MD, Cam JA, Larson EB, Martin GM, Deeb SS. 1998. The human FE65 gene: genomic structure and an intronic biallelic polymorphism associated with sporadic dementia of the Alzheimer type. Hum Genet 103:295-303.
14. Koo EH, Squazzo SL. 1994. Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J Biol Chem 269:17386-17389.
15. LeBlanc AC, Gambetti P. 1994. Production of Alzheimer 4-kDa beta-amyloid peptide requires the C-terminal cytosolic domain of the amyloid precursor protein. Biochem Biophys Res Commun 204:1371-1380.
16. McCarthy KD, de Vellis J. 1980. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890-902.
17. Nochlin D, Mackenzie AP, Bryant EM, Norwood TH, Sumi SM. 1993. A simple method of rapid freezing adequately preserves brain tissue for immunocytochemistry, light and electron microscopic examination. Acta Neuropathol (Berlin) 86:645-650.
18. Pearson RCA, Powell TPS. 1989. The neuroanatomy of Alzheimer's disease. Rev Neurosci 2:101-122.
19. Rudnicki MA, McBurney MW. 1987. Cell culture methods and induction of differentiation of embryonal carcinoma cell lines. In: Robertson EJ, editor. Teratocarcinoma and embryonic stem cells: a practical approach. Washington, DC: IRL Press. p. 19-50.
20. Russo T, Faraonio R, Minopoli G, De Candia P, De Renzis S, Zambrano N. 1998. Fe65 and the protein network centered around the cytosolic domain of the Alzheimer's β-amyloid precursor protein. FEBS Lett 434:1-7.
21. Sabo SL, Lanier LM, Ikin AF, Khorkova O, Sahasrabudhe S, Greengard P, Buxbaum JD. 1999. Regulation of β-amyloid secretion by FE65, an amyloid protein precursor-binding protein. J Biol Chem 274:7952-7957.
22. Simeone A, Duilio A, Fiore F, Acampora D, De Felice C, Faraonio R, Paolocci F, Cimino F, Russo T. 1994. Expression of the neuron-specific FE65 gene marks the development of embryo ganglionic derivatives. Dev Neurosci 16:53-60.
23. Smith CWJ, Patton JG, Nadal-Ginard B. 1989. Alternative splicing in the control of gene expression. Annu Rev Genet 23:527-577.
24. Trommsdorff M, Borg JP, Margolis B, Herz J. 1998. Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein. J Biol Chem 273:33556-33560.
25. van Leeuwen FW, de Kleijn DP, van den Hurk HH, Neubauer A, Sonnemans MA, Sluijs JA, Koycu S, Ramdjielal RDJ, Salehi A, Martens GJM, Grosveld FG, Peter J, Burbach H, Hol EM. 1998. Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. Science 279:242-247.
26. Xiang H, Hochman DW, Saya H, Fujiwara T, Schwartzkroin PA, Morrison RS. 1996. Evidence for p53-mediated modulation of neuronal viability. J Neurosci 16:6753-6765.
27. Zambrano N, Buxbaum JD, Minopoli G, Fiore F, De Candia P, De Renzis S, Faraonio R, Sabo S, Cheetham J, Sudol M, Russo T. 1997. Interaction of the phosphotyrosine interaction/phosphotyrosine binding-related domains of Fe65 with wild-type and mutant Alzheimer's beta-amyloid precursor proteins. J Biol Chem 272:6399-6405.
28. Zambrano N, Minopoli G, de Candia P. Russo T. 1998. The FE65 adaptor protein interacts through its PID1 domain with the transcription factor CP2/LSF/LBP1. J Biol Chem 273:20128-20133.